Zydus Lifesciences informs about disclosure

03 Jan 2024 Evaluate

Zydus Lifesciences has informed that the Company has received an Assessment Order of FY 2017-18 on the issue pertaining to Input Tax Credit (‘ITC’). The details as required under regulation 30 of Listing Regulations read with SEBI Circular are enclosed. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×